Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.

被引：0
|
作者：
Launonen, Inga-Maria P. [1 ,2 ]
Lyytikainen, Nuppu [1 ,2 ]
Casado, Julia [1 ,2 ]
Anttila, Ella A. [1 ,2 ]
Jacobson, Connor A. [3 ]
Lin, Jia R. [3 ]
Maliga, Zoltan [3 ]
Santaga, Sandro [4 ]
Elias, Kevin M. [4 ]
D'Andrea, Alan D. [3 ]
Konstantinopoulos, Panagiotis A. [3 ]
Sorger, Peter K. [3 ]
Farkkila, Anniina [1 ,2 ]
机构：
[1] Univ Helsinki, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2747
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian Cancer
    Wang, Yicheng
    Xie, Haoling
    Chang, Xiaohong
    Hu, Wenqi
    Li, Mengyao
    Li, Yi
    Liu, Huiping
    Cheng, Hongyan
    Wang, Shang
    Zhou, Ling
    Shen, Danhua
    Dou, Sha
    Ma, Ruiqiong
    Mao, Yunuo
    Zhu, Honglan
    Zhang, Xiaobo
    Zheng, Yuxuan
    Ye, Xue
    Wen, Lu
    Kee, Kehkooi
    Cui, Heng
    Tang, Fuchou
    CANCER RESEARCH, 2022, 82 (21) : 3903 - 3916
  • [22] The tumor immune microenvironment modulates response to chemotherapy in high-grade serous epithelial ovarian cancer
    Koti, Madhuri
    Edwards, Andrew
    Squire, Jeremy A.
    CANCER RESEARCH, 2014, 74 (19)
  • [23] The effect of neutrophil extracellular traps on tumor immune microenvironment of high-grade serous ovarian cancer
    Tamura, Kohei
    Matsumiya, Misaki
    Takahashi, Rei
    Futoh, Yurie
    Miyato, Hideyo
    Ohzawa, Hideyuki
    Saga, Yasushi
    Takei, Yuji
    Fujiwara, Hiroyuki
    Kitayama, Joji
    CANCER SCIENCE, 2024, 115 : 244 - 244
  • [24] Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
    Lee, Yong Jae
    Woo, Ha Young
    Kim, Yoo-Na
    Park, Junsik
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    Park, Eunhyang
    Joung, Je-Gun
    Lee, Jung-Yun
    CANCERS, 2022, 14 (09)
  • [25] Single-cell RNA-seq analysis of primary tumor and corresponding metastatic lesion in high-grade serous ovarian cancer.
    Shih, Andrew
    Menzin, Andrew
    Whyte, Jill
    Lovecchio, John
    Liew, Anthony
    Khalili, Houman
    Onel, Kenan
    Gregersen, Peter
    Lee, Annette
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 54 - 55
  • [26] Constitutional BRCA1 methylation and risk of incident triple-negative breast cancer and high-grade serous ovarian cancer.
    Lonning, Per Eystein
    Nikolaienko, Oleksii
    Pan, Kathy
    Kurian, Allison W.
    Eikesdal, Hans Petter Petter
    Pettinger, Mary
    Anderson, Garnet L.
    Prentice, Ross L.
    Chlebowski, Rowan T.
    Knappskog, Stian
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients
    Ji, Gang
    Yao, Qianlan
    Bao, Longlong
    Zhang, Jing
    Bai, Qianming
    Zhu, Xiaoli
    Tu, Xiaoyu
    Bi, Rui
    Zhou, Xiaoyan
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [28] Constitutional BRCA1 methylation is a major predisposition factor for high-grade serous ovarian cancer
    Dobrovic, Alexander
    Mikeska, Thomas
    Alsop, Kathryn
    Candiloro, Ida
    George, Joshy
    Mitchell, Gillian
    Bowtell, David
    CANCER RESEARCH, 2014, 74 (19)
  • [29] BRCA1 methylation status in high-grade serous ovarian cancer (HGSOC) patients (pts).
    Ruscito, Ilary
    Braicu, Elena Ioana
    Panici, Pierluigi Benedetti
    Chekerov, Radoslav
    Dimitrova, Desislava
    Ganapathi, Ram N.
    Vasconcelos, Ines
    Bellati, Filippo
    Fotopoulou, Christina
    Lichtenegger, Werner
    Olek, Sven
    Sehouli, Jalid
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Meisel, J. L.
    Hyman, D. M.
    Garg, K.
    Zhou, Q.
    Dao, F.
    Bisogna, M.
    Gao, J.
    Schultz, N. D.
    Grisham, R. N.
    Phillips, M.
    Iasonos, A.
    Kauff, N. D.
    Levine, D. A.
    Soslow, R. A.
    Spriggs, D. R.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2372 - +
12345